This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (115)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David W. Kinne, MD; Jeanne A. Petrek, MD; Michael P. Osborne, MD; Alfred A. Fracchia, MD; Angelo A. DePalo, MD; Paul Peter Rosen, MD

Arch Surg. 1989;124(1):33-36.

Abstract
• A total of 150 patients with in situ breast cancer were treated from 1970 through 1976, with a median follow-up of 11.5 years. There were 42 patients with microinvasion and 25 with bilateral disease, analyzed separately. Eight patients who became unavailable for follow-up within five years (but who had no evidence of disease [NED]) were excluded. Eighty-five patients had ductal carcinoma in situ, 43 had lobular carcinoma in situ, and 22 had a mixed type. Modified radical mastectomy was done in 112 cases. One of 128 patients had positive axillary nodes; axillary dissection is not indicated for in situ breast cancer. Of the 150 patients, one with ductal disease died of disease. Six died of other causes, free of disease. Of 18 treated by excision alone, two underwent mastectomy for recurrence and had NED. Patients with microinvasion had involved nodes in 10%, and 94% had NED. However, all bilateral cases had NED.

(Arch Surg 1989;124:33-36)

Author Affiliations
From the Breast Service, Department of Surgery (Drs Kinne, Petrek, Osborne, Fracchia, and DePalo) and Department of Pathology (Dr Rosen), Memorial Sloan-Kettering Cancer Center, New York.

Footnotes
Accepted for publication Sept 2, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.

Reprint requests to 1275 York Ave, New York, NY 10021 (Dr Kinne).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ductal Carcinoma In Situ, Complexities and Challenges
Leonard and Swain
JNCI J Natl Cancer Inst 2004;96:906-920.
ABSTRACT | FULL TEXT  

Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)
Morrow et al.
CA Cancer J Clin 2002;52:256-276.
ABSTRACT | FULL TEXT  

Age at Diagnosis and Outcome for Women With Ductal Carcinoma-In-Situ of the Breast: A Critical Review of the Literature
Vicini and Recht
JCO 2002;20:2736-2744.
ABSTRACT | FULL TEXT  

Treatment Selection in Ductal Carcinoma In Situ
Morrow and Schnitt
JAMA 2000;283:453-455.
FULL TEXT  

Prognosis in Women with a Carcinoma in Situ of the Breast: A Population-based Study in Sweden
Wärnberg et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:769-774.
ABSTRACT | FULL TEXT  

National Treatment Trends for Ductal Carcinoma In Situ of the Breast
Winchester et al.
Arch Surg 1997;132:660-665.
ABSTRACT  

In Situ or Localized Breast Cancer -- How Much Treatment Is Needed?
Swain
NEJM 1993;328:1633-1634.
FULL TEXT  

Ten-Year Follow-up of Breast Carcinoma In Situ in Connecticut
Ward et al.
Arch Surg 1992;127:1392-1395.
ABSTRACT  

Surgical Treatment of Ductal Carcinoma In Situ of the Breast: 10- to 20-Year Follow-up
Simpson et al.
Arch Surg 1992;127:468-472.
ABSTRACT  

Occult Breast Cancer Presenting With Axillary Metastases: Updated Management
Baron et al.
Arch Surg 1990;125:210-214.
ABSTRACT